251 related articles for article (PubMed ID: 19147540)
1. Mutual regulation of hypoxia-inducible factor and mammalian target of rapamycin as a function of oxygen availability.
Knaup KX; Jozefowski K; Schmidt R; Bernhardt WM; Weidemann A; Juergensen JS; Warnecke C; Eckardt KU; Wiesener MS
Mol Cancer Res; 2009 Jan; 7(1):88-98. PubMed ID: 19147540
[TBL] [Abstract][Full Text] [Related]
2. Mutations in the PI3K/PTEN/TSC2 pathway contribute to mammalian target of rapamycin activity and increased translation under hypoxic conditions.
Kaper F; Dornhoefer N; Giaccia AJ
Cancer Res; 2006 Feb; 66(3):1561-9. PubMed ID: 16452213
[TBL] [Abstract][Full Text] [Related]
3. Activation of HIF-1alpha in exponentially growing cells via hypoxic stimulation is independent of the Akt/mTOR pathway.
Dayan F; Bilton RL; Laferrière J; Trottier E; Roux D; Pouyssegur J; Mazure NM
J Cell Physiol; 2009 Jan; 218(1):167-74. PubMed ID: 18781596
[TBL] [Abstract][Full Text] [Related]
4. A quassinoid 6alpha-tigloyloxychaparrinone inhibits hypoxia-inducible factor-1 pathway by inhibition of eukaryotic translation initiation factor 4E phosphorylation.
Jin X; Jin HR; Lee D; Lee JH; Kim SK; Lee JJ
Eur J Pharmacol; 2008 Sep; 592(1-3):41-7. PubMed ID: 18639543
[TBL] [Abstract][Full Text] [Related]
5. Silibinin inhibits hypoxia-inducible factor-1alpha and mTOR/p70S6K/4E-BP1 signalling pathway in human cervical and hepatoma cancer cells: implications for anticancer therapy.
García-Maceira P; Mateo J
Oncogene; 2009 Jan; 28(3):313-24. PubMed ID: 18978810
[TBL] [Abstract][Full Text] [Related]
6. The human HIF (hypoxia-inducible factor)-3alpha gene is a HIF-1 target gene and may modulate hypoxic gene induction.
Tanaka T; Wiesener M; Bernhardt W; Eckardt KU; Warnecke C
Biochem J; 2009 Oct; 424(1):143-51. PubMed ID: 19694616
[TBL] [Abstract][Full Text] [Related]
7. Antagonism of the mammalian target of rapamycin selectively mediates metabolic effects of epidermal growth factor receptor inhibition and protects human malignant glioma cells from hypoxia-induced cell death.
Ronellenfitsch MW; Brucker DP; Burger MC; Wolking S; Tritschler F; Rieger J; Wick W; Weller M; Steinbach JP
Brain; 2009 Jun; 132(Pt 6):1509-22. PubMed ID: 19416948
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic strategy targeting the mTOR-HIF-1alpha-VEGF pathway in ovarian clear cell adenocarcinoma.
Miyazawa M; Yasuda M; Fujita M; Kajiwara H; Hirabayashi K; Takekoshi S; Hirasawa T; Murakami M; Ogane N; Kiguchi K; Ishiwata I; Mikami M; Osamura RY
Pathol Int; 2009 Jan; 59(1):19-27. PubMed ID: 19121088
[TBL] [Abstract][Full Text] [Related]
9. Sirolimus inhibits human pancreatic carcinoma cell proliferation by a mechanism linked to the targeting of mTOR/HIF-1 alpha/VEGF signaling.
Wang Y; Zhao Q; Ma S; Yang F; Gong Y; Ke C
IUBMB Life; 2007 Nov; 59(11):717-21. PubMed ID: 17968710
[TBL] [Abstract][Full Text] [Related]
10. Prolyl hydroxylases as regulators of cell metabolism.
Boulahbel H; Durán RV; Gottlieb E
Biochem Soc Trans; 2009 Feb; 37(Pt 1):291-4. PubMed ID: 19143649
[TBL] [Abstract][Full Text] [Related]
11. Suppression of PI3K/mTOR pathway rescues LLC cells from cell death induced by hypoxia.
Hamanaka Y; Mukai M; Shimamura M; Kitagawa T; Nishida T; Isohashi F; Ito T; Nishizawa Y; Tatsuta M; Matsuda H; Inoue M
Biochem Biophys Res Commun; 2005 Apr; 330(1):318-26. PubMed ID: 15781267
[TBL] [Abstract][Full Text] [Related]
12. Fatty acid synthase gene is up-regulated by hypoxia via activation of Akt and sterol regulatory element binding protein-1.
Furuta E; Pai SK; Zhan R; Bandyopadhyay S; Watabe M; Mo YY; Hirota S; Hosobe S; Tsukada T; Miura K; Kamada S; Saito K; Iiizumi M; Liu W; Ericsson J; Watabe K
Cancer Res; 2008 Feb; 68(4):1003-11. PubMed ID: 18281474
[TBL] [Abstract][Full Text] [Related]
13. Hypoxia signalling through mTOR and the unfolded protein response in cancer.
Wouters BG; Koritzinsky M
Nat Rev Cancer; 2008 Nov; 8(11):851-64. PubMed ID: 18846101
[TBL] [Abstract][Full Text] [Related]
14. A new pharmacologic action of CCI-779 involves FKBP12-independent inhibition of mTOR kinase activity and profound repression of global protein synthesis.
Shor B; Zhang WG; Toral-Barza L; Lucas J; Abraham RT; Gibbons JJ; Yu K
Cancer Res; 2008 Apr; 68(8):2934-43. PubMed ID: 18413763
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the mammalian target of rapamycin pathway and the effect of rapamycin on target expression and cellular proliferation in osteosarcoma cells from dogs.
Gordon IK; Ye F; Kent MS
Am J Vet Res; 2008 Aug; 69(8):1079-84. PubMed ID: 18672974
[TBL] [Abstract][Full Text] [Related]
16. Anemia and cerebral outcomes: many questions, fewer answers.
Hare GM; Tsui AK; McLaren AT; Ragoonanan TE; Yu J; Mazer CD
Anesth Analg; 2008 Oct; 107(4):1356-70. PubMed ID: 18806052
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of PKHD1 may cause S-phase entry via mTOR signaling pathway.
Zheng R; Wang L; Fan J; Zhou Q
Cell Biol Int; 2009 Sep; 33(9):926-33. PubMed ID: 19524688
[TBL] [Abstract][Full Text] [Related]
18. Deregulation of cap-dependent mRNA translation increases tumour radiosensitivity through reduction of the hypoxic fraction.
Rouschop KM; Dubois L; Schaaf MB; van den Beucken T; Lieuwes N; Keulers TG; Savelkouls KG; Bussink J; van der Kogel AJ; Koritzinsky M; Wouters BG
Radiother Oncol; 2011 Jun; 99(3):385-91. PubMed ID: 21665307
[TBL] [Abstract][Full Text] [Related]
19. Melatonin down-regulates HIF-1 alpha expression through inhibition of protein translation in prostate cancer cells.
Park JW; Hwang MS; Suh SI; Baek WK
J Pineal Res; 2009 May; 46(4):415-21. PubMed ID: 19552765
[TBL] [Abstract][Full Text] [Related]
20. Regulation of hypoxia-inducible factors during inflammation.
Frede S; Berchner-Pfannschmidt U; Fandrey J
Methods Enzymol; 2007; 435():405-19. PubMed ID: 17998066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
